1Lewandowsky F, Lutz W. Ein Fall einer bisher nicht beschriebenen Hauterkrankung (Epidermodysplasia verruciformis)[J]. Arch Dermatol Syph Bed, 1922, 141: 193-203.
2Kanerva LO, Johansson E, Niemi KM, et al. Epidermodysplasia verruciformis. Clinical and light-and electron-microscopic observations during etretinate therapy[J]. Arch Dermatol Res, 1985, 278(2): 153-160.
1Craven NM,Griffiths CE.Retinoids in the management of nonmelanoma skin cancer and melanoma[J].Cancer Surv,1996,26:267-288.
2Anadolu R,Oskay T,Erdem C,et al.Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a[J].J Am Acad Dermatol,2001,45(2):296-299.
3Jablonska S,Obalek S,Wolska H.Follow-up of patients with epidermodysplasia verruciformis treated with etretinate[J].Dermatologica,1986,173(4):196-199.
4Iraji F,Faghihi G.Epidermodysplasia verruciformis:association with isolated IgM deficiency and response to treatment with acitretin[J].Clin Exp Dermatol,2000,25(1):41-43.
5Gubinelli E,Posteraro P,Cocuroccia B,et al.Epidermodysplasia verruciformis with multiple mucosal carcinomas treated with pegylated interferon alfa and acitretin[J].J Dermatolog Treat,2003,14(3):184-188.
